Qunibi W, Moustafa M, Muenz LR, et al. A 1-year randomized trial of calcium acetate versus sevelamer on progression of coronary artery calcification in hemodialysis patients with comparable lipid control: the calcium acetate renagel evaluation-2 (CARE-2) study[J]. Am J Kidney Dis,2008, 51(6): 952-965.
Argile′s A, Mourad G. How do we have to use the calcium in the dialysate to optimize the management of secondary hyperparathyroidism[J]. Nephrol Dial Transpl, 1998, 13(Suppl 3): 62-64.
[4]
Eknoyan G, Levin A, Levin NW, et al. Bone metabolism and disease in chronic kidney disease[J]. Am J Kidney Dis, 2003, 42(Suppl 3): 7-201.
[5]
Johnson RJ, Feehally J. Comprehensive clinical nephrology[M]. Philadelphia: Hacourt Publishers, 2000: 1-11.
[6]
Holgado R, Haire H, Ross D, et al. Effect of a low calcium dialysate on parathyroid hormone secretion in diabetic patients on maintenance hemodialysis[J]. J Bone Miner Res, 2000, 15(5): 927-935.
[7]
Goodman WG, Goldin J, Kuizon BD, et al. Coronary artery calcification in young adults with end-stage renal disease who are undergoing dialysis[J]. N Eng J Med, 2000, 342(20): 1478-1483.
[8]
Brandi L, Melsen PK, Bro S, et al. Long-term effects of intermittent oral alphacalcidol, calcium carbonate and low-calcium dialysis, (1.25 mmol/L) on secondary hyperparathyroidism in patients on CAPD[J]. J Inter Med, 1998, 244(2): 121-131.
[9]
Amstrong A, Beer J, Noonan, et al. Reduced calcium dialysate in CAPD patients: efficacy and limitations[J]. Nephrol Dial Transplant, 1997, 12(6):1223-1228.
[10]
Young EW, Albert JM, Satayathum S, et. al. Predictors and consequences of altered mineral metabolism: the dialysis out comes and practice patterms study[J]. Kidney Int, 2005, 67(3): 1179-1187.
[11]
Bloek GA, Hulbert-Shearon TE, Levin NW, et al. Association of serum phosphorus and caleium x phosphate product with mortality risk in chronic hemodialysis patients: a national study[J]. Am J Kidney Dis, 1998, 31(4): 607-617.
[12]
Levin NW, Hulberg-shearron TE, Straderman RL, et al. Which causes of death are related to hyperphosphatemia in hemodialysis patients[J]. J Am Soc Nephrol, 1998, 9: 217A.
[13]
Bender F, Bernardini J, Piraino B. Calcium mass transfer with dialysate containing 1.25 and 1.75 mmol/L calcium in peritoneal dialysis patients[J]. Am J Kidney Dis, 1992, 20(4): 367-371.
